Nancy Stagliano, PhD, is a passionate leader in the field of neuroscience. With a background in biomedical and electrical engineering, she holds a PhD in neuroscience and has conducted postdoctoral research at Harvard Medical School. She has a track record of success as CEO of several biotech companies, including True North Therapeutics, iPierian, and CytomX Therapeutics. Nancy's dedication to developing therapies for patients is evident through her leadership in companies like Neuron23 and her involvement in philanthropic efforts, including serving on the board of PanCAN, a nonprofit organization focused on pancreatic cancer.